Screener
Altimmune ALT Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Altimmune’s 10-K, filed March 6, 2026.
- Filed
- Mar 6, 2026, 7:56 AM EST
- Fiscal year
- FY2025
- Accession
- 0001326190-26-000018
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 |
|---|---|---|
| Revenues | $41 | $20 |
| Operating expenses: | ||
| Research and development | 66,432 | 82,226 |
| General and administrative | 28,098 | 20,966 |
| Total operating expenses | 94,530 | 103,192 |
| Loss from operations | (94,489) | (103,172) |
| Other income (expense): | ||
| Interest expense | (1,636) | (9) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Altimmune's total revenue?
- Altimmune (ALT) reported total revenue of $26K in Q4 2025.
- How has Altimmune's total revenue changed year-over-year?
- Altimmune's total revenue increased by 420.0% year-over-year, from $5K to $26K.
- What is the long-term trend for Altimmune's total revenue?
- Over 4 years (2021 to 2025), Altimmune's total revenue has grown at a -68.9% compound annual growth rate (CAGR), from $4.41M to $41K.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Altimmune's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude